| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6082
PAX3 and PAX7 are closely related paired box family members expressed during early neural and myogenic development. Assay of PAX3 and PAX7 mRNA expression in embryonal rhabdomyosarcoma, neuroblastoma, Ewings sarcoma, and melanoma cell lines revealed tumor-specific expression patterns similar to the corresponding embryonic lineages. Although the mammalian PAX3 and PAX7 genes were reported to contain eight exons, we found that the predominant PAX3 and PAX7 transcripts in these tumor lines contain previously uncharacterized ninth exons. These splicing events alter the COOH-terminal coding regions of the encoded products but do not alter the transcriptional activity as assayed using a reporter gene with a model PAX3/PAX7 binding site. However, the findings of nearly identical COOH-terminal regions within the corresponding genes of the avian and fish genomes suggest conserved functional roles for these regions that require further investigation.
This article has been cited by other articles:
![]() |
C. Mao, X. Hu, and N. Li Identification and Expression Profile of a Novel Alternative Splicing of Pax7 in Chick Skeletal Muscle Poult. Sci., September 1, 2008; 87(9): 1919 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, S. Kumar, M. Slevin, and P. Kumar Functional Analysis of Alternative Isoforms of the Transcription Factor PAX3 in Melanocytes In vitro. Cancer Res., September 1, 2006; 66(17): 8574 - 8580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. He, G. Stevens, A. W. Braithwaite, and M. R. Eccles Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity Mol. Cancer Ther., June 1, 2005; 4(6): 996 - 1003. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Mackereth, S.-J. Kwak, A. Fritz, and B. B. Riley Zebrafish pax8 is required for otic placode induction and plays a redundant role with Pax2 genes in the maintenance of the otic placode Development, January 15, 2005; 132(2): 371 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Harris, E. White, E. S. Phillips, and K. A. Lillycrop The Expression of the Developmentally Regulated Proto-oncogene Pax-3 Is Modulated by N-Myc J. Biol. Chem., September 13, 2002; 277(38): 34815 - 34825. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pani, M. Horal, and M. R. Loeken Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis Genes & Dev., March 15, 2002; 16(6): 676 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Chansky, M. Hu, D. D. Hickstein, and L. Yang Oncogenic TLS/ERG and EWS/Fli-1 Fusion Proteins Inhibit RNA Splicing Mediated by YB-1 Protein Cancer Res., May 1, 2001; 61(9): 3586 - 3590. [Abstract] [Full Text] |
||||
![]() |
L. Yang, H. A. Chansky, and D. D. Hickstein EWS{middle dot}Fli-1 Fusion Protein Interacts with Hyperphosphorylated RNA Polymerase II and Interferes with Serine-Arginine Protein-mediated RNA Splicing J. Biol. Chem., November 22, 2000; 275(48): 37612 - 37618. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |